Altos-Labs on Bioeconhttps://en.bioecon.ru/companies/altos-labs/Recent content in Altos-Labs on BioeconHugoen-USMon, 20 Jul 2026 21:56:50 +0700Partial epigenetic reprogramminghttps://en.bioecon.ru/technology/partial-epigenetic-reprogramming/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/partial-epigenetic-reprogramming/Transient expression of Yamanaka reprogramming factors to reverse epigenetic markers of cellular aging without erasing cell identity — OSK gene therapy, AI-discovered reprogramming payloads and safer single-gene rejuvenation targets: Altos Labs, Retro Biosciences, NewLimit and Life Biosciences in the US, Shift Bioscience in the UK, and JingTong Life in China.Geroscience & senolyticshttps://en.bioecon.ru/technology/geroscience-senolytics/Fri, 03 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/geroscience-senolytics/Selectively clearing senescent ‘zombie’ cells or suppressing their inflammatory secretome to treat age-related disease at its molecular root, rather than one downstream condition at a time.